There were 2,461 press releases posted in the last 24 hours and 441,590 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Arch Oncology Announces First Patient Dosed in Phase 1/2 Clinical Trial of Anti-CD47 Antibody AO-176 in Multiple Myeloma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image